NCT05597462View on ClinicalTrials.gov

Impact of DFD-29 on Microbial Flora of Healthy, Adult Human Subjects When Administered Over 16 Weeks

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2022

Primary Completion Date

May 30, 2023

Study Completion Date

May 30, 2023

Conditions
Rosacea
Interventions
DRUG

Minocycline hydrochloride capsules

Minocycline hydrochloride capsules, 40 mg will be administered orally once daily for 16 weeks.

OTHER

Placebo

Placebo capsules will be administered orally once daily for 16 weeks.

Trial Locations (2)

79925

3A Research, LLC, El Paso

88011

3A Research, LLC, Las Cruces

Sponsors
All Listed Sponsors
collaborator

Dr. Reddy's Laboratories Limited

INDUSTRY

lead

Journey Medical Corporation

INDUSTRY

NCT05597462 - Impact of DFD-29 on Microbial Flora of Healthy, Adult Human Subjects When Administered Over 16 Weeks | Biotech Hunter | Biotech Hunter